IDiyas

For the Inventor, By the Inventor

Hennigsdorf, Germany

B.r.a.h.m.s Gmbh


USPTO Granted Patents = 75



Trademarks = 13

Forward Citations = 264

Loading Chart...
Loading Chart...

105 inventors (with patents filed for the assignee):

goldMedal Andreas Bergmann (49 out of 109 patents)

silverMedal Joachim Struck (48 out of 65 patents)

bronzeMedal Nils G Morgenthaler (18 out of 21 patents)

4.  Jana Papassotiriou (13 out of 13 patents)

5.  Darius Cameron Wilson (7 out of 7 patents)

6.  Leong Loke Ng (6 out of 6 patents)

7.  Oliver Hartmann (4 out of 5 patents)

8.  Aline Pehla (4 out of 4 patents)

9.  Stefan Kirsch (4 out of 4 patents)

10.  Hans Rupprecht (3 out of 3 patents)

11.  Stefan Blankenberg (3 out of 3 patents)

12.  Karl Lackner (3 out of 3 patents)

13.  Christoph Bickel (3 out of 3 patents)

14.  Gilbert Vassart (3 out of 19 patents)

15.  Sabine Costagliola (3 out of 3 patents)


Core Competencies:
Remote Patient Management
Biomarkers
Procalcitonin
Infectious Disease Diagnosis
Antibiotic Therapy Guidance
Risk Stratification
Myocardial Infarction
Chronic Kidney Disease
Neurophysin II
Adverse Event Prognosis
Immunoassay
Vasoactive Hormones

75 patents:

1. 12442825 - Prescription of remote patient management based on biomarkers (2025-10-14),
2. 12405279 - Method for preparing a sample (2025-09-02),
3. 12385926 - MMP-8 as a marker for identifying infectious disease (2025-08-12),
4. 12265092 - Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin (2025-04-01),
5. 12181474 - Biomarkers for the diagnosis of invasive fungal infections (2024-12-31),
6. 12153057 - Antibiotic therapy guidance based on procalcitonin in patients with comorbidities (2024-11-26),
7. 12000845 - Method for discharging a patient from an intensive care unit (2024-06-04),
8. 11835531 - Procalcitonin for the prognosis of adverse events (2023-12-05),
9. 11592450 - Diagnosis and risk stratification of fungal infections (2023-02-28),
10. 11402393 - Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints (2022-08-02),
11. 11391742 - Free histone proteins as biomarkers (2022-07-19),
12. 11327082 - Proadrenomedullin as a marker for abnormal platelet levels (2022-05-10),
13. 11241395 - Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease (2022-02-08),
14. 11041867 - ProADM and/or histones as markers indicating an adverse event (2021-06-22),
15. 10954298 - Method of obtaining a binder to prepro-vasopressin or fragments thereof (2021-03-23),
B.R.A.H.M.S GMBH is a leading biotechnology company specializing in in-vitro diagnostic products. With a focus on developing assays for clinical diagnostics, the company offers a wide range of high-quality products for the healthcare industry. B.R.A.H.M.S GMBH is dedicated to advancing medical science and improving patient care through continuous innovation and research.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
75 Patents

#1 in Hennigsdorf

#776 in Germany

#9,603 in the World

...
Hennigsdorf, Germany

B.r.a.h.m.s Gmbh

Forward Citations = 264

105 inventors:

goldMedal Andreas Bergmann (49 out of 109 patents)

silverMedal Joachim Struck (48 out of 65 patents)

bronzeMedal Nils G Morgenthaler (18 out of 21 patents)

4.  Jana Papassotiriou (13 out of 13 patents)

5.  Darius Cameron Wilson (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…